- Home
- BBY vs NBIX Comparison
BBY vs NBIX Comparison
Compare BBY & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBY
- NBIX
- Stock Information
- Founded
- BBY 1966
- NBIX 1992
- Country
- BBY United States
- NBIX United States
- Employees
- BBY N/A
- NBIX N/A
- Industry
- BBY Consumer Electronics/Video Chains
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BBY Consumer Discretionary
- NBIX Health Care
- Exchange
- BBY Nasdaq
- NBIX Nasdaq
- Market Cap
- BBY 15.6B
- NBIX 14.4B
- IPO Year
- BBY N/A
- NBIX 1996
- Fundamental
- Price
- BBY $76.88
- NBIX $137.03
- Analyst Decision
- BBY Buy
- NBIX Strong Buy
- Analyst Count
- BBY 19
- NBIX 17
- Target Price
- BBY $81.59
- NBIX $163.71
- AVG Volume (30 Days)
- BBY 3.2M
- NBIX 884.9K
- Earning Date
- BBY 08-28-2025
- NBIX 10-29-2025
- Dividend Yield
- BBY 4.94%
- NBIX N/A
- EPS Growth
- BBY N/A
- NBIX 2.97
- EPS
- BBY 3.63
- NBIX 3.39
- Revenue
- BBY $41,598,000,000.00
- NBIX $2,509,900,000.00
- Revenue This Year
- BBY $1.51
- NBIX $20.75
- Revenue Next Year
- BBY $1.59
- NBIX $14.73
- P/E Ratio
- BBY $21.18
- NBIX $40.41
- Revenue Growth
- BBY N/A
- NBIX 18.42
- 52 Week Low
- BBY $54.99
- NBIX $84.23
- 52 Week High
- BBY $101.04
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- BBY 58.82
- NBIX 42.80
- Support Level
- BBY $74.32
- NBIX $135.59
- Resistance Level
- BBY $78.67
- NBIX $148.00
- Average True Range (ATR)
- BBY 1.88
- NBIX 2.83
- MACD
- BBY 0.14
- NBIX -1.27
- Stochastic Oscillator
- BBY 74.17
- NBIX 11.60
About BBY Best Buy Co. Inc.
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.